Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus.

Brigette Marie ClarkeTom LoudovarisToni RadfordChris DrogemullerPatrick Toby CoatesDavid Torpy

Published in: Clinical case reports (2020)

Allogenic pancreatic islet cell transplantation is an appropriate treatment option to consider in the management of refractory cases of severe hypersensitivity to insulin in patients with type 1 diabetes mellitus.

Keyphrases

type diabetes
cell therapy
type iii
single cell
drug induced
glycemic control
early onset
blood pressure
high dose
stem cells
adipose tissue
metabolic syndrome
skeletal muscle
insulin resistance
weight loss